Purpose: To examine the short-term complications of arterial cannulation for intraoperative monitoring and their related risk factors.

Methods: We included adult inpatients (≥ 18 years old) who underwent an initial transradial access (TRA) cannulation and were scheduled for general surgery between April 8 and November 30, 2020. We used 20G arterial puncture needles for puncturing and manual compression for hemostasis. Demographic, clinical, surgical, anesthetic, and laboratory data were extracted from electronic medical records. Vascular, neurologic, and infectious complications of TRA cannulation were recorded and analyzed. Logistic regression analyses were used to identify risk factors related to TRA cannulation for intraoperative monitoring.

Results: Among 509 included patients, 174 developed TRA cannulation-related complications. Puncture site bleeding/hematoma and median nerve injury were observed in 158 (31.0%) and 16 (3.1%) patients, respectively. No patient developed cannula-related infections. Logistic regression analysis revealed increased odds of puncture site bleeding/hematoma in women (odds ratio 4.49, 95% CI 2.73-7.36; P < 0.001) and patients who received intraoperative red blood cell (RBC) suspension transfusion ≥ 4U (odds ratio 5.26, 95% CI 1.41-19.57; P = 0.01). No risk factors for nerve injury were identified.

Conclusion: Bleeding/hematoma were a common complication of TRA cannulation for intraoperative hemodynamic monitoring during general surgery. Median nerve injury may be an under recognized complication. Female sex and extensive intraoperative RBC transfusion are associated with an increased risk of bleeding/hematoma; however, the risk factors for nerve injury remain unclear.

Trial Registration: The study protocol was registered at https://www.chictr.org.cn (ChiCTR1900025140).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311751PMC
http://dx.doi.org/10.1186/s12871-023-02168-zDOI Listing

Publication Analysis

Top Keywords

tra cannulation
12
risk factors
8
transradial access
8
general surgery
8
cannulation intraoperative
8
logistic regression
8
puncture site
8
site bleeding/hematoma
8
cannulation
5
complications
4

Similar Publications

Background: Cardiac catheterization via the trans-radial approach (TRA) has shown several advantages over the trans-femoral approach (TFA) but with a concern of higher radiation exposure. Considering the growing experience with TRA, this study compares patient's radiation during coronary angiography using TRA versus TFA.

Methods: This study included consecutive patients undergoing coronary angiogram over a year at tertiary hospital performed by experienced operators through radial or femoral access.

View Article and Find Full Text PDF

Background: We aim to share our experience of transradial access (TRA) for cerebral angiography and intervention in five patients ranging from 6 days to 7 months of age.

Methods: In this institutional review board-approved, retrospective case series, we reviewed all patients who underwent TRA for cerebral angiography with and without intervention. We describe three techniques for radial artery cannulation, namely: (1) bareback; (2) with a micropuncture sheath; and (3) with an intravenous catheter.

View Article and Find Full Text PDF

Background: Venous outflow is the favored access for endovascular management of dialysis fistulas. However, transradial access (TRA) offers advantages in specific clinical scenarios. The study aims to compare the efficacy, feasibility, and safety of TRA and transvenous access (TVA) in the endovascular management of malfunctioning dialysis fistulas, addressing the existing gap in comprehensive literature.

View Article and Find Full Text PDF

Background: Transradial access (TRA) is not a common vascular access in children. We have been performing TRA actively to reduce puncture complications, and the purpose of this study was to investigate the safety and efficacy of TRA in young children.

Methods: The study included 29 patients aged 5-12 years who underwent diagnostic catheterization at Kurume University Hospital.

View Article and Find Full Text PDF
Article Synopsis
  • - Trastuzumab (Tra) can cause serious heart problems (cardiotoxicity) in cancer patients, but there's no reliable way to diagnose this issue early on.
  • - Researchers identified a potential biomarker, SLC6A6, using advanced bioinformatics and machine learning, which showed consistent expression across various datasets.
  • - Experiments in both cells and animals revealed that SLC6A6 levels drop significantly after Tra treatment, indicating its potential as a diagnostic marker and therapeutic target for early detection and treatment of Tra-induced cardiotoxicity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!